Search

everythinglearnresearchcommunity

for

Search:↓

Vitamin A may influence hair loss conditions like alopecia, but more research is needed to understand how.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

Higher CRBP1 levels are linked to more severe alopecia areata.

Newborn screening and gene therapy are expected to improve outcomes for Omenn syndrome patients.

2011 dermatological research found new skin aging markers, hair loss causes, skin defense mechanisms, and potential for new treatments.

Alopecia Areata is an autoimmune hair loss condition, with various treatments showing mixed effectiveness and no guaranteed cure.

Platelet-rich plasma treatment is not very effective for chronic severe alopecia areata.

Aged individuals heal wounds less effectively due to specific immune cell issues.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

Alopecia areata is a common autoimmune condition causing varying hair loss, diagnosed by specific patterns of inflammation around hair follicles, with several treatment options available.

The secretions of mesenchymal stem cells could be used for healing without using the cells themselves.

Hair follicle development is controlled by interactions between skin tissues and specific molecular signals.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Cushing's syndrome can cause serious health problems, and early treatment is crucial, but some issues may remain after treatment.

The skin has a complex immune system that is essential for protection and healing, requiring more research for better wound treatment.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Guidelines suggest various treatments for alopecia areata, but leaving it untreated is also an option as 80% cases may recover on their own.

Artificial skin development has challenges, but new materials and understanding cell behavior could improve tissue repair. Also, certain growth factors and hydrogel technology show promise for advanced skin replacement therapies.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

A man with severe hair loss and skin disease regrew his hair with no side effects after taking tofacitinib.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Alopecia areata is a common autoimmune disease affecting about 2% of people, causing significant disability and often associated with mental health issues and other autoimmune conditions.

Vitamin D is important for skin health and may affect conditions like psoriasis and hair loss, but more research is needed to understand its role fully.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Children with atopic dermatitis often have sleep problems, affecting their growth and behavior.